Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Is Roche's pRED finally ready to step out from behind Genentech for its closeup? Probably not
8 years ago
Bioregnum
R&D
Shire hit by a setback as Hunter syndrome drug fails late-stage study
8 years ago
R&D
Stepping up behind Sanofi, Genentech rolls the DiCE on a new small molecule discovery pact
8 years ago
Pharma
Aerie bags an early OK for its self-described blockbuster glaucoma drug Rhopressa, recruiting 100 reps
8 years ago
Pharma
Apotex founder and wife's death now suspected homicide; Spectrum CEO Rajesh Shrotriya fired
8 years ago
News Briefing
On a new deal spree, Regeneron buys into ISA in pursuit of a checkpoint combo
8 years ago
Pharma
Severe job cuts at Teva incite massive worker strikes, shutting Israel down
8 years ago
R&D
Pharma
What’s the big hurry, Novartis? Pharma giant scores a PRV shortcut for $130M
8 years ago
Pharma
Allergan and Gedeon Richter ready to knock on FDA's door after a positive PhIII for cariprazine in bipolar depression
8 years ago
R&D
AbbVie vet John Leonard moves up to the helm at CRISPR/Cas9 pioneer Intellia, focused on looming human studies
8 years ago
People
Boehringer antes up on a €627.5M deal for rights to Autifony’s schizophrenia drugs
8 years ago
Pharma
Bain leads big $70M round as Aptinyx plunges deeper into NMDA work
8 years ago
Financing
Andy Boyer joins Teva exodus; Achaogen shuffles executive lineup
8 years ago
Peer Review
Celgene forges cancer pact with CRT; FDA OKs Pfizer's Xeljanz as treatment for psoriatic arthritis
8 years ago
News Briefing
Four months after patient death, FDA's hold lifted on Alnylam's fitusiran
8 years ago
Pharma
The 50 most active biotech VC funds in 2017
8 years ago
Financing
Amicus CEO lobbied FDA to reverse FDA’s rejection of migalastat, claiming a delay of up to 7 years
8 years ago
Pharma
Grail taps Genentech vet Jennifer Cook as CEO, building expectations for 2018
8 years ago
People
Peer Review
Novartis oncology CEO Bruno Strigini is calling it quits
8 years ago
People
Peer Review
One of Merck's pivotal stomach cancer trials for Keytruda flops, just months after an FDA OK
8 years ago
R&D
Galapagos snags co-promotion rights on filgotinib — just before Gilead’s lock-up pact expires
8 years ago
R&D
Pharma
Jnana launches with $50M to spotlight an unexplored protein territory
8 years ago
Financing
Startups
Pfizer's Ixifi gets approved as third Remicade biosimilar; Novo Nordisk licenses reMYND's diabetes program in ...
8 years ago
News Briefing
Bristol-Myers teams up with Opdivo maker Ono Pharmaceutical on new I/O programs
8 years ago
R&D
Pharma
First page
Previous page
1077
1078
1079
1080
1081
1082
1083
Next page
Last page